Twice as nice: Dual impact of etanercept treatment on skin and joint patient-reported outcomes of psoriatic arthritis patients from the experience, diagnosing, understanding care and treatment with etanercept (educate) trial - 21/08/11
Bruce Strober, MD, PhD, New York University Medical Center, Department of Dermatology, New York, NY, United States; Jeffrey J. Crowley, MD, private practice, Bakersfield, CA, United States; J. Michael Woolley, PhD, Seth R. Stevens, MD, Amgen Inc., Thousand Oaks, CA, United States
Le texte complet de cet article est disponible en PDF. P2819 Dr. Strober has been a speaker and/or consultant to Amgen, Genentech, and Biogen Idec. Dr. Crowley has no financial conflicts of interest regarding Embrel or the abstract contents. Research funded by Immunex Corporation, a wholly owned subsidiary of Amgen Inc., and by Wyeth Research |
Vol 52 - N° 3S
P. P201 - mars 2005 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?